Pharmacokinetic evaluation of piperacillin-tazobactam

Y Hayashi, JA Roberts, DL Paterson… - Expert opinion on drug …, 2010 - Taylor & Francis
Importance of the field: Piperacillin-tazobactam is a frequently prescribed intravenous
antibiotic for moderate to severe infections used in hospital settings because of its broad …

Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin‐tazobactam

MK Kim, B Capitano, HM Mattoes… - … : The Journal of …, 2002 - Wiley Online Library
Study Objective. To compare the pharmacokinetic and pharmacodynamic profiles of two
dosing regimens for piperacillin‐tazobactam against commonly encountered pathogens …

Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing

DS Burgess, T Waldrep - Clinical therapeutics, 2002 - Elsevier
Background: Although intermittent bolus dosing is currently the standard of practice for many
antimicrobial agents, beta-lactams exhibit time-dependent bacterial killing. Maximizing the …

Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections

TW Felton, WW Hope, BM Lomaestro… - Antimicrobial agents …, 2012 - Am Soc Microbiol
While extended infusions of piperacillin-tazobactam (TZP) are increasingly used in practice,
the effect of infusion on the pharmacokinetic (PK) profile of TZP has not been widely …

Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses

I El-Haffaf, JA Caissy, A Marsot - Clinical pharmacokinetics, 2021 - Springer
Piperacillin-tazobactam is a potent β-lactam/β-lactamase inhibitor antibiotic commonly
prescribed in the intensive care unit setting. Admitted patients often show large variability in …

Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients

KM Shea, SC Cheatham, MF Wack, DW Smith… - International journal of …, 2009 - Elsevier
The objective of this study was to evaluate the steady-state pharmacokinetics and
pharmacodynamics of piperacillin/tazobactam, administered by prolonged infusion, in …

Pharmacokinetics of piperacillin–tazobactam: intermittent dosing versus continuous infusion

C Buck, N Bertram, T Ackermann, T Sauerbruch… - International journal of …, 2005 - Elsevier
In the present study 24 hospitalized patients requiring empirical antibiotic treatment were
randomly assigned to receive the β-lactam antibiotic/β-lactamase inhibitor combination …

Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens

DJ Occhipinti, SL Pendland… - Antimicrobial agents …, 1997 - Am Soc Microbiol
The pharmacokinetics and pharmacodynamics of two multiple-dose regimens of piperacillin-
tazobactam (3.375 g every 6 h and 4.5 g every 8 h) were evaluated at steady state for 12 …

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review

GT Mah, VH Mabasa, I Chow… - Annals of …, 2012 - journals.sagepub.com
Objective: To perform a qualitative systematic review of the evidence comparing traditional
strategies against prolonged intermittent or continuous infusion strategies for piperacillin …

Population pharmacokinetics of piperacillin in sepsis patients: should alternative dosing strategies be considered?

MG Andersen, A Thorsted, M Storgaard… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Sufficient antibiotic dosing in septic patients is essential for reducing mortality. Piperacillin-
tazobactam is often used for empirical treatment, but due to the pharmacokinetic (PK) …